The story of Viagra, and its creator copyright, presents a challenging case study for investors. Initially a blockbuster drug, yielding billions in revenue , its exclusivity period created a wave of knock-off medications, significantly impacting its dominance. While some pharmaceutical companies may attempt to capitalize on related treatments , the